Hard Time After The Recent Run KemPharm Stock
Posted onIn the past year, KemPharm, Inc. (NASDAQ:KMPH at https://www.webull.com/quote/nasdaq-kmph) has been really successful. Over the 12-month time frames KMPH is up 191% (TTM). Sadly, it seems like this stock is not going to survive at such high prices. The KMPH stock was just $4.05 per share in July last, for example. The stock was tripled to 13.60 dollars by the end of August 2020 and up to 18.72 dollars by the middle of December. Then it was a flowing blow, and it was $11.20 at the end of the year. So KMPH stock was down to a little less than 1% at today’s opening price of $10.69 per action.
Clinical stage
Investors may also influence a short-selling of this biotech stock by the various short-sellers. Recent positive news about their lead medication nominee has helped this. KemPharm is a pharmaceutical corporation of the developmental stage whose key possible …